Translucent collagen formulations with a cytotoxic drug

Details Translucent collagen formulations with a cytotoxic drug Translucent collagen formulations with a cytotoxic drug

1995-04-28

1998-05-12

Webman, Edward J.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Matrices

424423, 424426, A61K 910, A61K 4742

Patent

active

057501467

ABSTRACT:
Disclosed are translucent proteinaceous compositions comprising collagen and an effective amount of a compatible cytotoxic drug which compositions are characterized by having a single collagen transition temperature of less than about 45.degree. C. Such compositions possess enhanced retention of the cytotoxic drug at the site of injection and are optically translucent.

REFERENCES:
patent: Re33375 (1990-10-01), Luck et al.
patent: 2589210 (1952-03-01), McGinty
patent: 4177263 (1979-12-01), Rosenberg et al.
patent: 4230687 (1980-10-01), Sair et al.
patent: 4322398 (1982-03-01), Reiner et al.
patent: 4347234 (1982-08-01), Wahlig et al.
patent: 4349530 (1982-09-01), Royer
patent: 4391797 (1983-07-01), Folkman et al.
patent: 4407787 (1983-10-01), Stemberger
patent: 4424208 (1984-01-01), Wallace et al.
patent: 4536387 (1985-08-01), Sakamoto et al.
patent: 4619913 (1986-10-01), Luck et al.
patent: 4863732 (1989-09-01), Nathan et al.
patent: 5002071 (1991-03-01), Harrell
patent: 5385738 (1995-01-01), Yamahira et al.
patent: 5490984 (1996-02-01), Freed
Maugh, Science, 212:1128-1129 (1981).
Miyata, et al., Cancer Research, 43:4670-4675 (1983).
McLaughlin, et al., Cancer Research, 38:1311-1316 (1978).
Bier, et al., Cancer, 44:1194-1200 (1979).

Affiliated with

Also associated with

Rating

Translucent collagen formulations with a cytotoxic drug does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Translucent collagen formulations with a cytotoxic drug, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Translucent collagen formulations with a cytotoxic drug will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-977077